Literature DB >> 17561014

Assisted living nursing practice: medication management: part 2 supervision and monitoring of medication administration by unlicensed assistive personnel.

Ethel Mitty1, Sandi Flores.   

Abstract

More than half the states permit assistance with or administration of medications by unlicensed assistive personnel or med techs. Authorization of this nursing activity (or task) is more likely because of state assisted living regulation than by support and approval of the state Board of Nursing. In many states, the definition of "assistance with" reads exactly like "administration of" thereby raising concern with regard to delegation, accountability, and liability for practice. It is, as well, a hazardous path for the assisted living nurse who must monitor and evaluate the performance of the individual performing this nursing task. This article, the second in a series on medication management, addresses delegation, standards of practice of medication administration, types of medication errors, the components of a performance evaluation tool, and a culture of safety. Maintaining professional standards of assisted living nursing practice courses throughout the suggested recommendations.

Mesh:

Year:  2007        PMID: 17561014     DOI: 10.1016/j.gerinurse.2007.04.002

Source DB:  PubMed          Journal:  Geriatr Nurs        ISSN: 0197-4572            Impact factor:   2.361


  2 in total

1.  "Meds Are a Real Tricky Area": Examining Medication Management and Regulation in Assisted Living.

Authors:  Candace L Kemp; Shanzhen Luo; Mary M Ball
Journal:  J Appl Gerontol       Date:  2010-09-13

2.  Evaluation of a support worker role, within a nurse delegation and supervision model, for provision of medicines support for older people living at home: the Workforce Innovation for Safe and Effective (WISE) Medicines Care study.

Authors:  Cik Yin Lee; Christine Beanland; Dianne Goeman; Ann Johnson; Juliet Thorn; Susan Koch; Rohan A Elliott
Journal:  BMC Health Serv Res       Date:  2015-10-06       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.